Announcement on behalf of OBIGEN that BOD nominated Dr. Heidi Wang as the Chairperson

Announcement on behalf of OBIGEN the change of its financial and accounting officer

Announcement on behalf of OBIGEN the resignation of Chief Commercial Officer

Announcement of not Distributing Dividends in 2024

Announcement on behalf of OBIGEN that its institutional director changes its representative

Announcement on behalf of OBIGEN the resignation of Chairperson

Announcement on behalf of OBIGEN of the resignation of its institutional director

Announcement of 2024 Consolidated Financial Statements were approved by the Board of Directors

The Company's Board of Directors resolved to convene the 2025 Annual General Shareholders' Meeting

Announcement on behalf of Amaran’s BOD to resolve the reference date for conversion of employee stock options to common shares